Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) is now available.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced a supplemental notice for its 2024 Annual General Meeting, scheduled for May 22, 2025. The key highlight of the announcement is a special resolution to grant the Board a general mandate to issue additional shares, subject to certain conditions and regulatory approvals, which could impact the company’s capital structure and market positioning.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing medical technology solutions and services, with a market focus on leveraging technological advancements for healthcare improvements.
Average Trading Volume: 982,621
Technical Sentiment Signal: Strong Buy
Find detailed analytics on 2291 stock on TipRanks’ Stock Analysis page.